3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
5
NIH
2
INDUSTRY
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Colorectal Neoplasms
1
Interventions
Fluorouracil
74
Leucovorin
48
Oxaliplatin
44
Cisplatin
40
Capecitabine
39
Gemcitabine
37
Radiotherapy
30
Irinotecan
28
Cetuximab
21
Paclitaxel
15
Bevacizumab
12
Docetaxel
10
Taxes
9
durvalumab
8
dehydroftorafur
8
Surgical Procedures, Operative
8
Mitomycin
8
Specimen Handling
7
Platinum
7
Folfox protocol
7
Carboplatin
7
Albumin-Bound Paclitaxel
7
130-nm albumin-bound paclitaxel
7
S 1 (combination)
6
Panitumumab
6
Watchful Waiting
5
Imatinib Mesylate
5
Gene Expression Profiling
5
Epirubicin
5
tremelimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Sulindac
×
Gastrointestinal
×
Clear all
NCT01349881
2026-04-02
PACES
SWOG Cancer Research Network
Phase 3
Active not recruiting
354 enrolled